Antiplatelet therapy remains the mainstay in preventing aberrant platelet activation in
pathophysiological conditions such as myocardial infarction, ischemia, and stroke. Although …

Introduction: Eptifibatide is a glycoprotein IIb/IIIa inhibitor that blocks the final common
pathway of platelet aggregation. Its major adverse effect is bleeding. Balancing its safety and …

The goals of therapy in acute myocardial infarction (AMI) are to achieve rapid and optimal
restoration of flow in the infarct-related vessel and to maintain this initial result in the long …

Platelet reactivity plays a pivotal role in the pathogenesis of ischemic cardiovascular
disorders. Among the proposed pharmacologic targets for antiplatelet therapy, glycoprotein …

Consumption of flavonol rich food including fruit and vegetables is associated with reduced
cardiovascular risks [127, 219]. Flavonols exert a variety of biological activities including …